Loading...

PE anti-human CD45 Antibody

Pricing & Availability
Clone
HI30 (See other available formats)
Regulatory Status
RUO
Workshop
IV N816
Other Names
LCA, T200
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
HI30_PE_071307
Human peripheral blood lymphocytes stained with HI30 PE
  • HI30_PE_071307
    Human peripheral blood lymphocytes stained with HI30 PE
  • HI30_PE_CD45_Antibody_3_042922
    PE anti-human CD45 Antibody Human peripheral blood was stained with CD45 (clone HI30) PE (solid line) or mouse IgG1, κ PE isotype control (dashed line).

    Data was acquired on the Moxi Flow, exported, and processed using FlowJo software.
See PE spectral data
Cat # Size Price Quantity Check Availability Save
304007 25 tests 23€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
304008 100 tests 53€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
304058 100 µg 59€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
304039 500 tests 281€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD single chain type I membrane glycoprotein also known as leukocyte common antigen (LCA) and T200. It is a tyrosine phosphatase expressed on the plasma membrane of all hematopoietic cells, except erythrocytes and platelets. CD45 is a signaling molecule that regulates a variety of cellular processes including cell growth, differentiation, cell cycle, and oncogenic transformation. CD45 plays a critical role in T and B cell antigen receptor-mediated activation by dephosphorylating substrates including p56Lck, p59Fyn, and other Src family kinases. CD45 non-covalently associates with lymphocyte phosphatase-associated phosphoprotein (LPAP) on T and B lymphocytes. CD45 has been reported to bind galectin-1 and to be associated with several other cell surface antigens including CD1, CD2, CD3, and CD4.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
µg size: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections and formalin-fixed paraffin-embedded tissue sections9, inhibition of CD45 functions4, immunofluorescence11, Western blotting3, and spatial biology (IBEX)16,17.

It was found that the HI30 clone and the 2D1 clone can cross block each other's binding.

Application References
  1. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  2. Kishihara K, et al. 1993. Cell 74:143.
  3. Esser M, et al. 2001. J. Virol. 75:6173. (WB)
  4. Yamada T, et al. 2002. J. Biol. Chem. 277:28830.
  5. Nagano M, et al. 2007. Blood 110:151.
  6. Jiang Q, et al. 2008. Blood 112:2858. PubMed
  7. Morozov A, et al. 2010. Clin Cancer Res. 16:5630. PubMed
  8. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  9. Friedman T, et al. 1999. J. Immunol. 162:5256. (IHC)
  10. Oeztuerk-Winder F, et al. 2012. EMBO J. 31:3431. (FC) PubMed
  11. Rees LE, et al. 2003. Clin. Exp. Immunol. 134:497. (IF)
  12. Lee J, et al. 2015. J Exp Med. 212:385. PubMed
  13. Breton G, et al. 2015. J Exp Med. 212:401. PubMed
  14. Marquardt N, et al. 2015. J Immunol. 6:2467. PubMed
  15. Bushway ME, et al. 2014. Biol Reprod. 90(5): 110. (IF) PubMed
  16. Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed
  17. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  2. Guzzi N et al. 2018. Cell. 173(5):1204-1216 . PubMed
  3. Hsu JI et al. 2018. Cell stem cell. 23(5):700-713 . PubMed
  4. Eri Yamada et al. 2018. Cell host & microbe. 23(1):110-120 . PubMed
  5. Yuan J et al. 2018. Molecular cell. 72(2):380-394 . PubMed
  6. Ackermann M, et al. 2018. Nat Commun. 9:5088. PubMed
  7. Tancharoen W, et al. 2019. Mol Med Rep. 19:5123. PubMed
  8. Morton JJ, et al. 2018. Mol Carcinog. 57:1651. PubMed
  9. Ye C, et al. 2017. J Virol. 91:e01389-23. PubMed
  10. Lee HJ, et al. 2017. Oncotarget. 8:113345. PubMed
  11. Nakano Y, et al. 2017. PLoS Pathog. 13:e1006348. PubMed
  12. Sato K, et al. 2010. J Virol. 84:9546. PubMed
  13. Sato K, et al. 2014. PLoS Pathog. 10:1004453. PubMed
  14. Weinstein S, et al. 2016. Proc Natl Acad Sci U S A. 113: 16 - 22. PubMed
  15. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  16. Vincent V, et al. 2020. Biotechniques. 68:325. PubMed
  17. Singh A, et al. 2020. Mol Oncol. 1.901388889. PubMed
  18. Tu C, et al. 2021. Theranostics. 2.1. PubMed
  19. Gumber D, et al. 2020. eLife. 9:00. PubMed
  20. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  21. Morton JJ, et al. 2020. Molecular Cancer Research. 19(2):346-357. PubMed
  22. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  23. Thompson ER, et al. 2020. Am J Transplant. . PubMed
  24. Melzer C, et al. 2020. Int J Mol Sci. :21. PubMed
  25. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  26. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  27. Hu Q, et al. 2021. Nat Commun. 12:2186. PubMed
  28. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  29. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  30. Fei D, et al. 2021. Front Cell Dev Biol. 9:687258. PubMed
  31. Schwabenland M, et al. 2021. Acta Neuropathol. 142:923. PubMed
  32. Witkowski M, et al. 2021. Nature. 600:295. PubMed
  33. Arenas EJ, et al. 2021. Nat Commun. 12:1237. PubMed
  34. Zong D, et al. 2021. BMC Biol. 19:79. PubMed
  35. Zhou T, et al. 2022. Sci Adv. 8:eabj9617. PubMed
  36. Wu J, et al. 2022. Nat Commun. 13:676. PubMed
  37. Daskou M, et al. 2022. PLoS Pathog. 18:e1010160. PubMed
  38. Gao G, et al. 2022. Am J Cancer Res. 12:1934. PubMed
  39. Gong Y, et al. 2021. Aging (Albany NY). 13:20629. PubMed
  40. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  41. Zhang B, et al. 2022. Stem Cells Int. 2022:2236250. PubMed
  42. Cai S, et al. 2022. Cell Biosci. 12:115. PubMed
  43. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  44. Alcántara-Hernández M, et al. 2021. Nat Protoc. 16:4855. PubMed
  45. Burger ML, et al. 2021. Cell. 184:4996. PubMed
  46. Binnewies M, et al. 2021. Cell Rep. 37:109844. PubMed
  47. Alisjahbana A, et al. 2021. Front Immunol. 12:752104. PubMed
  48. Wang W, et al. 2022. Int J Mol Sci. 23:. PubMed
  49. Zhang J, et al. 2022. Int J Mol Sci. 23:. PubMed
  50. Martínez-Sabadell A, et al. 2022. STAR Protoc. 3:101712. PubMed
  51. Costa MHG, et al. 2021. Biotechnol J. 16:e2000389. PubMed
  52. Hagel J, et al. 2021. J Immunol. 206:3073. PubMed
  53. Labedz-Maslowska A, et al. 2021. Cells. 10: . PubMed
  54. Woan KV, et al. 2021. Cell Stem Cell. 28:2062. PubMed
  55. Omer-Javed A, et al. 2022. Cell. 185:2248. PubMed
  56. Polisetti N, et al. 2022. Bio Protoc. 12: . PubMed
  57. Yüce M, et al. 2022. J Cell Biochem. 123:1966. PubMed
  58. Martínez-Sabadell A, et al. 2022. Cell Rep. 41:111430. PubMed
  59. Hopke A, et al. 2022. iScience. 25:105226. PubMed
  60. Robb KP, et al. 2022. Front Immunol. 13:972095. PubMed
  61. Ferreira-Baptista C, et al. 2022. Bioengineering (Basel). 9: . PubMed
  62. Leick MB, et al. 2022. Cancer Cell. 40:494. PubMed
  63. Aubrey BJ, et al. 2022. Nat Cancer. 3:595. PubMed
  64. Silva ATF, et al. 2022. Int J Mol Sci. 23:. PubMed
  65. Wang J, et al. 2023. ACS Sens. 8:1200. PubMed
  66. Jenkins E, et al. 2023. Nat Commun. 14:1611. PubMed
  67. Palam LR, et al. 2023. JCI Insight. 8:. PubMed
  68. Hu X, et al. 2023. Nat Commun. 14:2020. PubMed
  69. Liu Y, et al. 2023. Int J Stem Cells. . PubMed
  70. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  71. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
RRID
AB_314395 (BioLegend Cat. No. 304007)
AB_314396 (BioLegend Cat. No. 304008)
AB_2564156 (BioLegend Cat. No. 304058)
AB_2562057 (BioLegend Cat. No. 304039)

Antigen Details

Structure
Tyrosine phosphatases, type I transmembrane protein, 180-240 kD (multiple isoforms)
Distribution

Hematopoietic cells, not expressed in circulating erythrocytes or platelets

Function
TCR and BCR mediated activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
Hematopoietic stem and progenitors, Mesenchymal Stem Cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References
  1. Thomas M. 1989. Annu. Rev. Immunol. 7:339.
  2. Trowbridge I, et al. 1994. Annu. Rev. Immunol.12:85.
Gene ID
5788 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Customers Also Purchased

FITC anti-human CD45
Clone: HI30

APC anti-human CD45
Clone: HI30

PE anti-human CD19
Clone: HIB19

APC anti-human CD3
Clone: UCHT1

Go To Top Version: 2    Revision Date: 04.25.2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account